Metraipolis › archive › dc_3ed1840b4ebf

Five-year outcomes of the STOP-AD randomised controlled trial: Long-term effects of early emollient therapy in high-risk infants — Europe PMC PMID:42973282

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42973282
DOI
10.1111/pai.70517
License (as archived)
solo-consultazione
Archived
2026-11-07T16:02:51.430Z
SHA-256 of the archived text
524acb3a76f221f909869e2a18635db81a8d8912ee167c0686dd677bb5a6cc61
Stable URL of this page
https://metraipolis.com/documento/dc_3ed1840b4ebf

How to cite

Five-year outcomes of the STOP-AD randomised controlled trial: Long-term effects of early emollient therapy in high-risk infants — Europe PMC PMID:42973282 — Europe PMC (en), https://europepmc.org/article/MED/42973282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ed1840b4ebf (Metraipolis archive dc_3ed1840b4ebf, sha256 524acb3a76f221f909869e2a18635db81a8d8912ee167c0686dd677bb5a6cc61)
BibTeX
@misc{dc3ed1840b4ebf,
  title = {Five-year outcomes of the STOP-AD randomised controlled trial: Long-term effects of early emollient therapy in high-risk infants — Europe PMC PMID:42973282},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42973282},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ed1840b4ebf; sha256 524acb3a76f221f909869e2a18635db81a8d8912ee167c0686dd677bb5a6cc61},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42973282. Agents can read the archived copy with the MCP tool read_document.